Vol 25, No 2 (2020)
Published online: 2020-03-01

open access

Page views 169
Article views/downloads 242
Get Citation

Connect on Social Media

Connect on Social Media

Obesity in patients with carcinoma cervix increases the risk of adverse events

Ramaiah Vinay Kumar1, Suman Bhasker2
DOI: 10.1016/j.rpor.2019.12.024
Rep Pract Oncol Radiother 2020;25(2):212-216.


Obesity has become epidemic both in developed and developing countries. Socio-economic (SE) development has resulted in increased prevalence of obesity across all social groups in developing countries that is contrary to the effects of rising SE status on prevalence of obesity in the developed world. Obesity is not only associated with metabolic syndrome, cardiovascular disease, diabetes but is also a risk factor for cancer and is responsible for increased cancer mortality. Published articles have reported higher rates of treatment failure and adverse events (AEs) of anti-cancer therapy in obese patients with carcinoma cervix in comparison to their normal body mass index (BMI) counterparts. Hence, there is a need to elucidate factors that may increase the risk of AEs. Aim of this paper is to discuss the delivery of radiotherapy, concurrent chemotherapy and their effect on AEs in obese patients with carcinoma cervix.

Article available in PDF format

View PDF Download PDF file

Reports of Practical Oncology and Radiotherapy